Serum-borne factor(s) of 1,1-dichloroethylene and 1,2-dichlorobenzene- treated mice inhibited in vitro antibody forming cell response and natural killer cell activity

Toxicology Letters

Volumn 94, Issue 2, 1998, Pages 93-101

  Ban, M ^a   Hettich, D ^a   Goutet, M ^a   Binet, S ^a  

^a INSTITUT NATIONAL DE RECHERCHE ET DE SÉCURITÉ   (France)

Author keywords

1,1 Dichloroethylene; 1,2 Dichlorobenzene; Immunosuppression; Serum borne factor; Tissue injury

Indexed keywords

1,2 DICHLOROBENZENE; ANTIBODY; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VINYLIDENE CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCING CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMORAL IMMUNITY; KIDNEY INJURY; LIVER INJURY; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SERUM FACTOR; SPLEEN CELL;

ANIMALS; ANTIBODY-PRODUCING CELLS; CELL DIVISION; CELL LINE; CHLOROBENZENES; DICHLOROETHYLENES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; KIDNEY; KILLER CELLS, NATURAL; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; SPLEEN; SUPPRESSOR FACTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0032583894     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(97)00109-4     Document Type: Article

References (26)

1. Ader R., Feten D., Cohen N. Interaction between the brain and the immune system. Annu. Rev. Pharmacol. Toxicol. 30:1990;561-602.
2. Ban M., Hettich D., Huguet N., Cavelier L. Nephrotoxicity mechanism of 1,1-dichloroethylene in mice. Toxicol. Lett. 78:1995;87-92.
3. Brondeau M.T., Ban M., Bonnet P., Guenier J.P., de Ceaurriz J. Concentration-related changes in blood and tissue parameters of hepatotoxicity and their interdependence in rats exposed to bromobenzene and 1,2-dichlorobenzene. Toxicol. Lett. 31:1986;159-166.
4. Chayen, J., 1973. Enzyme histochemistry phosphatase. In: Chayen, J., Bitensky, L., Butcher, R.G. (Eds.), Practical Histochemistry. Wiley, Chichester, pp. 106-139.
5. Compton M.M., Caron L.M., Cidlowski J.A. Glucocorticoid action on the immune system. Steroid Biochem. 27:1987;201-208.
6. Cunningham A., Szenberg G.A. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 14:1968;599-600.
7. 1 mice by carbon tetrachloride. I. Carbon tetrachloride-induced suppression of helper T-lymphocyte function is mediated by a serum borne factor. Toxicology. 85:1993;67-84.
8. Driscoll K.E., Maurer J.K. Cytokine and growth factor release by alveolar macrophages: potential biomarkers of pulmonary toxicity. Toxicol. Pathol. 10:1991;398-405.
9. Fuchs B.A., Sanders V.M. The role of brain-immune interactions in immunotoxicology. CRC Crit. Rev. Toxicol. 24(2):1994;151-176.
10. Jeon Y.J., Han S.H., Yang K.H., Kaminski N.E. Induction of liver-associated transforming growth factor β1 (TGF-β1) m RNA expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines. Toxicol. Appl. Pharmacol. 144:1997;27-35.
11. Kammüler M.E. Recombinant human interleukin-6: Safety issues of a pleiotropic growth factor. Toxicology. 105:1995;91-107.
12. Kovacs E.J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol. Today. 12:1991;17-23.
13. Kushner, I., Machiewicz, A., 1993. The acute phase response: an overview. In: Kushner, I., Baumann, H., Mackiewicz, A. (Eds.), Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Implications. CRC Press, Boca Raton, FL, pp. 3-20.
14. Penn I. Tumors of immunocompromised patient. Annu. Rev. Med. 39:1988;63-73.
15. Sanders V.M., Powell-Olivier F.E. β-2-Adrenoreceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J. Immunol. 148:1992;1822-1828.
16. Sanders V.M., Fuchs B.A., Pruett S.B., Kerkvliet N.I., Kamiski N.E. Symposium on indirect mechanisms of immune modulation. Fund. Appl. Toxicol. 17:1991;641-650.
17. Schlesinger M.J. Heat shock proteins. J. Biol. Chem. 265:1990;12111-12114.
18. Short R.D., Winston J.M., Minor J.L., Hong C.B., Seifter J., Lee C.C. Toxicity of vinylidene chloride in mice and rats and its alteration by various treatments. J. Toxicol. Environ. Health. 3:1977;913-921.
19. Sztein B.M., Vogel N.S., Sipe D.J., Murphy A.P., Mizel S., Oppenheim J.J., Rosenstrich L.D. The role of macrophages in the acute-phase response: S.A.A. inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol. 63:1981;146.
20. Thurmond L.M., House R.V., Lauer L.D., Dean J.H. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene in vitro. Toxicol. Appl. Pharmacol. 93:1988;369-377.
21. Tomar R.S., Lim S., Gill S.S. The effects of epoxidized xenobiotics on mitogen responsiveness and antibody-producing ability of marine spleen cells in vitro. Int. J. Immunopharmacol. 13:1991;57-65.
22. Vandebriel R.J., Meredith C., Scott M.P., Gleichman E., Bloksma N., Erve H.M.V., Descotes J., Loveren H.K. Early indicators of immunotoxicity: development of molecular biological test batteries. Hum. Exp. Toxicol. 15(Suppl. 1):1996;S2-S9.
23. Wachstein M., Meisel E. Histochemistry of substrate specific phosphatases at a physiological pH. J. Histochem. Cytochem. 4:1956;424-425.
24. Welch W.J. Mammalian stress response: cell physiology, structure/function of stress proteins, and implication for medicine and disease. Physiol. Rev. 72:1992;1063-1075.
25. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous nuclease activation. Nature. 284:1980;555-556.
26. Young R.A., Elliott T.J. Stress proteins, infection and immune surveillance. Cell. 59:1989;5-8.